| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.7M | +47.7% |
| SG&A Expense | $11.8M | +36.1% |
| Operating Income | -$44.5M | -75.6% |
| Interest Expense | $850K | -64.6% |
| Pre-tax Income | -$17.7M | +32.2% |
| Income Tax | $13K | -43.5% |
| Net Income | -$17.7M | +32.3% |
| EPS (Basic) | $1.47 | +188.2% |
| EPS (Diluted) | $3.36 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.9M | +13.1% |
| Current Assets | $20.5M | +16.4% |
| Total Assets | $43.2M | +72.7% |
| Current Liabilities | $8.3M | -26.0% |
| Long-term Debt | $5.4M | -51.7% |
| Stockholders' Equity | $24.1M | +683.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.0M | -73.7% |
| Capital Expenditures | $30K | -40.0% |
| Investing Cash Flow | $715K | -63.4% |
| Financing Cash Flow | $38.4M | +1223.7% |
| Free Cash Flow | -$37.0M | -73.5% |
| +558.8% |